Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Pseudomembranous Colitis after 5-fluorouracil Chemotherapy in Rectal Cancer Patient

Cheon SH, Kim KH

  • KMID: 772852
  • Korean J Gastroenterol.
  • 2005 Nov;46(5):319-320.
No abstract availble
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Interstitial Lung Disease Associated with Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin

Park S, Jung JJ, Kim GB, Yoon HS, Ko SH, Ko JE, Lee YS

Oxaliplatin with 5-fluorouracil plus leucovorin (FOLFOX) has become the standard treatment in patients with colorectal cancer. Among known toxicities induced by oxaliplatin, hematological, gastrointestinal and neurological toxicities are common. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Wernicke's Encephalopathy Following Fluorouracil-based Chemotherapy

Cho IJ, Chang HJ, Lee KE, Won HS, Choi MY, Nam EM, Mun YC, Lee SN, Seong CM

The pyrimidine antimetabolite 5-fluorouracil (5-FU) is a chemotherapeutic agent used widely for various tumors. Common side effects of 5-FU are related to its effects on the bone marrow and gastrointestinal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Therapy-Related Acute Myeloid Leukemia Following 5-Fluorouracil Chemotherapy

Park HJ, Choi JH, Lee KA, Kim HC, Nam YS, Oh YH, Lee WS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
5-Fluorouracil-induced leukoencephalopathy in patients with breast cancer

Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH

The purpose of this study is to determine the characteristic clinical features, radiologic findings, and precipitating and prognostic factors in the patients with breast cancer and with 5-Fluorouracil (5-FU)-induced leukoencephalopathy....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Unpredicted Severe Toxicity after 5-Fluorouracil Treatment due to Dihydropyrimidine Dehydrogenase Deficiency

Baek JH, Kim JG, Kim SN, Kim DH, Sohn SK, Hong YJ, Lee KB

Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of 5-fluorouracil (5-FU). Thus, patients with a DPD deficiency are at risk of developing severe 5-FU-associated toxicity. A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Neurotoxicity Following 5-Fluorouracil-based Chemotherapy

Ki SS, Jeong JM, Kim SH, Jeong SH, Lee JH, Han CJ, Kim YC, Lee JO, Hong YJ

  • KMID: 1758683
  • Korean J Intern Med.
  • 2002 Mar;17(1):73-77.
5-Fluorouracil (5-FU) is a commonly used chemotherapeutic agent. However, its neurotoxicity is rare and not well recognized. We report a case of 5-FU neurotoxicity with organic brain syndrome and progression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr